Cargando…
Efficacy and Safety of Edoxaban 15 mg According to Renal Function in Very Elderly Patients With Atrial Fibrillation: A Subanalysis of the ELDERCARE-AF Trial
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876417/ https://www.ncbi.nlm.nih.gov/pubmed/35226559 http://dx.doi.org/10.1161/CIRCULATIONAHA.121.057190 |
| _version_ | 1784658170248953856 |
|---|---|
| author | Yoshida, Tetsuro Nakamura, Akihiro Funada, Junichi Amino, Mari Shimizu, Wataru Fukuzawa, Masayuki Watanabe, Saori Hayashi, Takuya Yamashita, Takeshi Okumura, Ken Akao, Masaharu |
| author_facet | Yoshida, Tetsuro Nakamura, Akihiro Funada, Junichi Amino, Mari Shimizu, Wataru Fukuzawa, Masayuki Watanabe, Saori Hayashi, Takuya Yamashita, Takeshi Okumura, Ken Akao, Masaharu |
| author_sort | Yoshida, Tetsuro |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8876417 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-88764172022-03-03 Efficacy and Safety of Edoxaban 15 mg According to Renal Function in Very Elderly Patients With Atrial Fibrillation: A Subanalysis of the ELDERCARE-AF Trial Yoshida, Tetsuro Nakamura, Akihiro Funada, Junichi Amino, Mari Shimizu, Wataru Fukuzawa, Masayuki Watanabe, Saori Hayashi, Takuya Yamashita, Takeshi Okumura, Ken Akao, Masaharu Circulation Correspondence Lippincott Williams & Wilkins 2022-03-01 2022-03-01 /pmc/articles/PMC8876417/ /pubmed/35226559 http://dx.doi.org/10.1161/CIRCULATIONAHA.121.057190 Text en © 2022 The Authors. https://creativecommons.org/licenses/by/4.0/Circulation is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access article under the terms of the Creative Commons Attribution (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited. |
| spellingShingle | Correspondence Yoshida, Tetsuro Nakamura, Akihiro Funada, Junichi Amino, Mari Shimizu, Wataru Fukuzawa, Masayuki Watanabe, Saori Hayashi, Takuya Yamashita, Takeshi Okumura, Ken Akao, Masaharu Efficacy and Safety of Edoxaban 15 mg According to Renal Function in Very Elderly Patients With Atrial Fibrillation: A Subanalysis of the ELDERCARE-AF Trial |
| title | Efficacy and Safety of Edoxaban 15 mg According to Renal Function in Very Elderly Patients With Atrial Fibrillation: A Subanalysis of the ELDERCARE-AF Trial |
| title_full | Efficacy and Safety of Edoxaban 15 mg According to Renal Function in Very Elderly Patients With Atrial Fibrillation: A Subanalysis of the ELDERCARE-AF Trial |
| title_fullStr | Efficacy and Safety of Edoxaban 15 mg According to Renal Function in Very Elderly Patients With Atrial Fibrillation: A Subanalysis of the ELDERCARE-AF Trial |
| title_full_unstemmed | Efficacy and Safety of Edoxaban 15 mg According to Renal Function in Very Elderly Patients With Atrial Fibrillation: A Subanalysis of the ELDERCARE-AF Trial |
| title_short | Efficacy and Safety of Edoxaban 15 mg According to Renal Function in Very Elderly Patients With Atrial Fibrillation: A Subanalysis of the ELDERCARE-AF Trial |
| title_sort | efficacy and safety of edoxaban 15 mg according to renal function in very elderly patients with atrial fibrillation: a subanalysis of the eldercare-af trial |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876417/ https://www.ncbi.nlm.nih.gov/pubmed/35226559 http://dx.doi.org/10.1161/CIRCULATIONAHA.121.057190 |
| work_keys_str_mv | AT yoshidatetsuro efficacyandsafetyofedoxaban15mgaccordingtorenalfunctioninveryelderlypatientswithatrialfibrillationasubanalysisoftheeldercareaftrial AT nakamuraakihiro efficacyandsafetyofedoxaban15mgaccordingtorenalfunctioninveryelderlypatientswithatrialfibrillationasubanalysisoftheeldercareaftrial AT funadajunichi efficacyandsafetyofedoxaban15mgaccordingtorenalfunctioninveryelderlypatientswithatrialfibrillationasubanalysisoftheeldercareaftrial AT aminomari efficacyandsafetyofedoxaban15mgaccordingtorenalfunctioninveryelderlypatientswithatrialfibrillationasubanalysisoftheeldercareaftrial AT shimizuwataru efficacyandsafetyofedoxaban15mgaccordingtorenalfunctioninveryelderlypatientswithatrialfibrillationasubanalysisoftheeldercareaftrial AT fukuzawamasayuki efficacyandsafetyofedoxaban15mgaccordingtorenalfunctioninveryelderlypatientswithatrialfibrillationasubanalysisoftheeldercareaftrial AT watanabesaori efficacyandsafetyofedoxaban15mgaccordingtorenalfunctioninveryelderlypatientswithatrialfibrillationasubanalysisoftheeldercareaftrial AT hayashitakuya efficacyandsafetyofedoxaban15mgaccordingtorenalfunctioninveryelderlypatientswithatrialfibrillationasubanalysisoftheeldercareaftrial AT yamashitatakeshi efficacyandsafetyofedoxaban15mgaccordingtorenalfunctioninveryelderlypatientswithatrialfibrillationasubanalysisoftheeldercareaftrial AT okumuraken efficacyandsafetyofedoxaban15mgaccordingtorenalfunctioninveryelderlypatientswithatrialfibrillationasubanalysisoftheeldercareaftrial AT akaomasaharu efficacyandsafetyofedoxaban15mgaccordingtorenalfunctioninveryelderlypatientswithatrialfibrillationasubanalysisoftheeldercareaftrial |